Dare Bioscience, Inc. (DARE) stock
DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.16 (-26.57%)
Close on Nov 17, 2026Market cap $6.56MP/E –Yield –
Dare Bioscience gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 71.3%, against 100.0% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 71.3% | −28.7 |
| FY2024 | Dec 31, 2024 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -70.6% | – |
| Q1 FY2026 | Mar 31, 2026 | -58.9% | – |
| Q1 FY2025 | Mar 31, 2025 | 100.0% | – |
See a number that looks wrong?